Matthew Miller, MD
Otolaryngology · Omaha, NENPI 1326435215
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $269 of the $444 with a category attached, or 60.5%. 9 manufacturers reported payments, led by Smith+Nephew at 45.1% of the total. Reporting peaked in 2020 at $218 and has fallen 65.5% since, to $75 in 2025. That places this record below the midpoint for otolaryngology clinicians in NE, where the typical reported total is $741.
Across 14 payments — averaging $31.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$200
- Zimmer Biomet$107
- Inspire Medical Systems, Inc.$34
- Stryker$19
- Acclarent, Inc$19
- Integra Lifesciences Corporation$18
- plus $46 from 3 others
What the payments were for
- Food & beverage$26960%
- Education$17640%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 2 | $200 |
| Zimmer Biomet | 4 | $107 |
| Inspire Medical Systems, Inc. | 2 | $34 |
| Stryker | 1 | $19 |
| Acclarent, Inc | 1 | $19 |
| Integra Lifesciences Corporation | 1 | $18 |
| Medtronic | 1 | $18 |
| GSK | 1 | $14 |
| Aesculap, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROCISE MAX$176
How this compares
$444 in reported general payments places this provider in the 35th percentile of 86 otolaryngology providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 17 | $2,248 |
| Fluticasone Propionate | 95 | $2,183 |
| Dexamethasone Sodium Phosphate | 18 | $1,249 |
| Ipratropium Bromide | 21 | $831 |
| Azelastine Hcl | 26 | $829 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 50 | $697 |
| Omeprazole | 36 | $662 |
| Doxycycline Hyclate | 52 | $587 |
| Famotidine | 23 | $532 |
| Mupirocin | 57 | $506 |
| Montelukast Sodium | 26 | $479 |
| Lidocaine Hcl ViscousLidocaine Hcl | 18 | $339 |
| Nystatin | 14 | $165 |
| Prednisone | 43 | $160 |
| Levothyroxine Sodium | 14 | $126 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Omaha
- Rahul VarmanOmaha$13K
- Daniel O'BrienOmaha$10K
- Wallace DuffOmaha$8K
- Tyler BlissOmaha$4K
- Adam PleasOmaha$4K
- Kyle StansiferOmaha$3K
- Jessica Moran-HansenOmaha$3K
- Jason TalmadgeOmaha$3K
- Thomas DoblemanOmaha$3K
- Stanley SchackOmaha$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.